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Abstract
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Background—Schizophrenia is a chronic disabling disorder for which current treatments are
only partially effective. While the evaluation of novel interventions is a high priority, loss to
followup is a major threat to validity.
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Methods—Pattern mixture modeling is a statistical technique that incorporates information on
patterns of retention that may bias comparisons between randomized treatment groups. This study
used pattern mixture mixed model (PMMM) in the analysis of outcomes of a two-year clusterrandomized trial, the Recovery after an Initial Schizophrenia Episode-Early Treatment Program,
which compared a coordinated specialty care intervention called NAVIGATE to usual community
care (CC). PMM-adjusted outcome differences between NAVIGATE and CC were estimated by
the weighted-average of effects across the retention patterns.
Results—Compared to the original analysis, PMMM improved model fit and the estimated
effectiveness of NAVIGATE as compared to CC. On the Quality of Life Scale NAVIGATE
effectiveness increased by 1.50 points (25.4%); on the Positive and Negative Syndrome Scale, by
1.72 points (39.8%), and on the Calgary Depression Scale by 0.49 points (62.1%). PMMM did not
improve model fit for employment days, substance use days, or hospital days.

Author Manuscript

Conclusion—Use of PMMM improved model fit and increased the estimated differences
between NAVIGATE and CC for major outcomes. Patients with differential retention patterns may
have different outcome trajectories. PMMM is a useful tool for addressing potential biases arising
from these differences.

INTRODUCTION

Author Manuscript

Randomized clinical trials are essential tools for evaluating the effectiveness of new
treatments. A major impediment to the validity of randomized clinical trials is the
differential retention or loss to follow-up between treatment groups. Such differences can
bias estimates of the differential effectiveness of treatments in randomized trials because
they undermine the assumption that treatment groups are equivalent since patients with
better or worse prognosis may be more likely to drop out of one group as compared to the
other. In addition, patients with different patterns of retention may have different outcome
trajectories within or across treatment groups, regardless of differences in overall rates of
retention.
The problem of differential retention or dropout may be especially important in studies of
severe mental illness, and especially in cases of first episode psychosis, because patients
with these disorders are often less likely to participate for the full duration of a study due to
poor psychosocial functioning and impaired insight into their illness (Mohamed et al., 2009).

Author Manuscript

There has been particular interest in recent years in early intervention in psychosis and in
first episode schizophrenia in particular. It has been hypothesized that early intervention can
substantially improve both short and long-term outcomes because it prevents the
deterioration in functioning that is believed to come with prolonged untreated or undertreated psychosis (Addington, 2007; Álvarez-Jiménez et al., 2011; Bird et al., 2010). Several
recent trials of intensive early intervention in psychosis have shown promising results
lending support for this hypothesis (Craig et al., 2004; Gafoor et al., 2010; Garety et al.,
2006; Kane et al., 2015; Petersen et al., 2005; Srihari et al., 2015).
The NIMH-funded Recovery After an Initial Schizophrenia Episode-Early Treatment
Program (RAISE-ETP) study (Kane et al., 2016) is currently the largest real-world study of
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specialized coordinated care for first episode psychosis yet conducted in the United States.
This multisite, two-year study showed significant benefits for a coordinated specialty care
intervention called NAVIGATE in quality of life and symptoms as compared to usual
community care (CC). There were, however, substantial differences in retention patterns
between the two conditions, presumably because NAVIGATE patientts were more engaged
in treatment and less likely to drop out as they received more intensive and comprehensive
services. While 129 of 223 NAVIGATE patients (57.8%) completed the 24-month
assessment, only 76 of 181 (41.9%) of CC patients did so. Whether this differential follow
up biased the results of this study, and whether modeling differences in retention would alter
the results, has not been examined.

Author Manuscript

A major methodological advance in this area in recent decades has been the use of mixed
models which allow the use of all available data even when some data are missing from
some subjects (Gueorguieva and Krystal, 2004; Lavori et al., 1990). However, mixed models
are based on the assumption that data are missing at random (MAR) given observed
measurements (Little and Rubin, 2002) and may be of uncertain validity when there is
extensive loss to follow-up. MAR is an untestable assumption which may well be violated
(Fitzmaurice et al., 2008) since loss to follow-up may be dependent on the missing outcome.
While improving retention through aggressive follow-up and outcome assessment is the best
way to minimize dropout bias, statistical remedies may also be used.

Author Manuscript

For a brief review of the analytic approaches including pattern mixture model (PMM) for
dealing with data that are Missing Not at Random (MNAR) in clinical trials (Little and
Rubin, 2002), please see Dziura et al. (2013). Molenberghs et al. (2002) used imputation
method in their PMM. Mixed-effects analysis has also been an appealing approach in PMM
where discrete variables for dropout patterns are used in regular mixed-effects model (Little,
1993; Hedeker and Gibbons, 1997; Demirtas and Schafer, 2003). This paper uses the pattern
mixture mixed model (PMMM) approach. In this approach, participants in a clinical trial are
stratified post-hoc according to the discrete groups representing their observed pattern of
retention, or missing data, and each retention pattern has its pattern-specific
parameterization in its own mixed-effect model. The weighted average of estimated
outcomes across retention patterns in such models can then be calculated. We used several
pattern-specific mixed-effect models while the mixed-effect PMM used a common mixedeffect model with terms of dropout patterns included as predictor but the two PMMs are
otherwise similar.
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Using different parameters for different retention patterns in PMM is thus a type of missing
not at random (MNAR) model in which missing responses depend on the missingness
pattern and vice versa. The PMM therefore may correct some bias when the MAR
assumption is violated, however, it may still suffer bias if the missing response depends on
additional unobserved variables besides the missingness pattern.
In this study, we used PMMMs to characterize the differential retention patterns among the
subjects in RAISE-ETP, and to explore whether such models improve the goodness of fit of
the outcome analyses and modify the estimated magnitude of group differences.
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METHODS
Sample
A total of 404 individuals aged 15 to 40 who presented for treatment for a first episode
psychosis (FEP) and who had been prescribed antipsychotic medication for less than six
months in lifetime, were enrolled between 2010–2012: 223 in NAVIGATE and 181 in CC. A
CONSORT diagram of recruitment has been previously published (Kane et al., 2016).
Thirty-four community mental health treatment centers were randomized to NAVIGATE or
CC with equal probability following a national invitation and selection process. None of the
centers withdrew after randomization.
Outcomes

Author Manuscript

Trained clinician interviewers who were masked to study participants’ treatment assignment
assessed the primary outcome measure, the Quality of Life Scale (QLS) (Heinrichs et al.,
1984), using two-way, live video conferencing at baseline and at 6, 12, 18, and 24 months.
The Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) and the Calgary
Depression Scale for Schizophrenia (CDSS) (Addington et al., 1990) were also completed
by the interviewers. Days of employment or school attendance, days in the hospital and days
of alcohol or drug use were documented at monthly interviews using structured self-report
questions.
Statistical Analysis

Author Manuscript

Identifying variables associated with dropout—Among patients who had a baseline
visit, we first used a time-to-dropout model with frailty terms (Clayton, 1978) for each
individual variable, to identify patient characteristics associated with dropping out of the
study for each of the baseline and time-varying covariates listed in Table 1. Because the trial
was a clustered randomized trial in which the two treatment conditions were randomized at
the site-level rather than the patient-level, we used frailty terms to account for clustering of
individual patients within sites. Particularly, in the time-to-dropout models with frailty
terms, patients within a site share the same frailty value to account for correlation of data
among patients within the same site. Frailty terms serve a similar role as random effects in
linear mixed model regression analyses.

Author Manuscript

Analysis with pattern mixture mixed model—We groups individual study
participants using three different approaches to the classification of retention patterns. The
first approach was based on the number of follow-up visits out of a possible total of four
(range=0 to 4). The second approach was based on the time of the last follow-up visit (0, 6,
12, 18, or 24 months). The third approach added an additional indicator variable to the
second approach to represent the situation in which patients missed an assessment and then
completed at least one subsequent assessment (i.e., who had intermittent missing data) and
otherwise were set to zero. The three different approaches to characterizing retention
patterns serve as sensitivity analyses to compare how treatment effects change under
different missingness classifications.
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For each outcome using PMMM, with the addition of a class variable distinguishing
different retention patterns in each of the three classification approaches described above, a
pattern-specific mixed model within each retention pattern was fitted. For all the patterns
with at least one followup visit, the pattern-specific mixed models were similar to those
mixed model in the original trial report (Kane et al., 2016). The mixed models included term
of time, the interaction between treatment group and time, and baseline measures that had
been determined to be significantly different between treatment groups and significant for
predicting the outcome. Specifically, the baseline covariates included were male gender,
student status, and PANSS baseline score (Kane et al., 2016). The term for time was the
square root of months since randomization which resulted approximately linear relationship
between time and outcome (Kane et al., 2016). The model also included individual-specific
and site-specific random intercept and slope of time. For patients in Stratum 0 who had only
baseline measurements without followup visit, no model term involving time was included
in their pattern-specific mixed models. For the outcome measures assessed monthly (days of
work, substance use and hospitalization), mixed negative binomial regressions were
conducted with terms analogous to the linear mixed models except with only random
intercepts for individuals and sites. As there was no statistically significant difference
between the two treatment groups for baseline measures of the outcomes except for the
PANSS, baseline values were used as outcomes. Since there was a statistically significant
difference in the baseline PANSS between the two treatment groups, the baseline PANSS
was not used as an outcome but instead the treatment indicator was used as covariate for
PANSS to account for baseline difference.

Author Manuscript

In the pattern mixture mixed models, additional indicator variables were included to
represent the patterns of missing data. In addition, terms representing the interaction of
retention pattern by treatment group, retention pattern by time, and the three-way interaction
of retention pattern by treatment by time were also included.

Author Manuscript

Comparing treatment effects between pattern mixture mixed model and linear
mixed model—For each outcome in each of the three approaches, the model-fitted
difference in outcomes between treatment groups was estimated for each stratified retention
pattern. The retention pattern-specific effect is the model-estimated difference in outcome
between the NAVIGATE group and the CC group at the end of study (24 months). Across all
the three approaches in our PMMM, for patients in the Stratum 0 who had only baseline
measurements, no pattern-specific effect was calculated as no term involving time was
included in the mixed model for the baseline only pattern. The difference in the patternspecific effect between a retention pattern and the referent stratum was evaluated with a
Wald test of the difference. The referent pattern was the stratum in which the patients had all
four follow-up visits under Approach 1, or in which the patients had a last visit at month 24
under Approaches 2 and 3. By comparing to the referent pattern, we can understand how the
effectiveness of NAVIGATE among the dropouts differed from the outcome among those
who had the most follow-up visits in the trial.
Next, the overall treatment effect in a given PMM for each outcome was obtained by
averaging the estimated pattern-specific effect across the retention patterns, weighting by the
proportion of patients in each retention pattern. The standard errors of these averages were
Schizophr Res. Author manuscript; available in PMC 2019 May 01.
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calculated using the delta method (Casella and Berger, 2002). The magnitude of the resultant
treatment effect could then be compared to that in the original linear mixed model.
In addition, the model fits of the regular mixed model and the three PMMMs for each
outcome were typically compared using the Bayesian Information Criterion (BIC) (Schwarz
1978) which serves a method for model selection that takes into account of both fit and
parsimony among candidate models. The PMMMs are nonnested models. BIC applied to
both nested and nonnested models. A model with a smaller BIC is preferred.

RESULTS
Sample

Author Manuscript

Characteristics of the sample have been previously published (Kane et al., 2016). Frailty
models showed CC patients were more likely to drop out than NAVIGATE patients (HR
1.55, p-value 0.02). Older patients were less likely to drop out (HR 0.97 per year, p-value
0.02) as were patients with a higher baseline and time-varying scores on the common objects
and activities subscale of QLS (HR 0.93, p-value 0.04). Patients with a higher self-rated
likelihood for their next visit were also less likely to drop out (HR 0.91, 0.84, 0.98, pvalue=0.01). No other baseline or time-varying measures were predictive of dropout at p<.05
(Table 1).
Retention Patterns and Model Fit of the PMMMs

Author Manuscript

The number and proportion of patients in each pattern are shown in Table 2 for the three
approaches. Of the patients that were enrolled and completed baseline assessment, 83
(20.5%) left the study before the first post-baseline visit at 6 months: 46 (25.4%) in CC and
37 (16.6%) in NAVIGATE. Since outcomes for these patients are not obtainable, their
outcomes were not modeled as a separate category, and thus they were de facto treated as if
their outcomes were similar to those of patients in the other retention patterns taken together.
For the approach based on the number of follow-up assessments, 50 (15.6%) had one
follow-up assessment, 49 (15.3%) two follow-up assessments, 67 (20.9%) three follow-up
assessments, and 155 (48.3%) completed all four follow-up assessments (Table 2, upper
panel). There was no significant difference in the distribution of these patterns between the
two treatment groups (χ2 = 1.65, df=3, p=0.65). Data for the other two approaches are
presented in the other panels in Table 2.

Author Manuscript

For each of the QLS, the PANSS total score, and the CDSS, the three approaches of
retention classifications all exhibited a better model fit than the original mixed model, as
demonstrated by lower BICs than the model with the regular mixed model (Table 3).
Furthermore, the best-fit PMMM was the one under Approach 3 of using the last visit time
and intermittent missingness for pattern distinction. (Table 3). Model fit was not improved
by the PMMMs for days of attending work or school, an index of daily use of alcohol or
drugs during the past month, or for days of hospitalization in the past month presumably
(Supplementary Table 1).
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To evaluate how differences in the outcomes between the two treatment groups vary across
retention patterns, Tables 4 showed the differences in treatment group outcomes on the QLS,
PANSS and CDSS for each retention pattern based on the best-fit PMMM, the ones under
Approach 3 of using the last visit time and intermittent missingness for pattern classification.
For each outcome group differences between NAVIGATE and CC were greater in the
retention patterns with earlier dropout, although these differences were statistically
significant only for the PANSS at month 6 (Table 4a, 4b, and 4c). Examination of outcomes
specifically at 6 months, for example, showed that among patients in the retention pattern
that dropped out at 6-months the NAVIGATE group showed its greatest magnitude of
superior improvement to CC on all three outcomes: the QLS (17.36, SE = 11.52) (top row,
Table 4a); the PANSS (−29.88, SE = 10.85) (top row, Table 4b) and the CDSS (−5.38, SE =
2.53) (top row, Table 4c). Within the retention pattern with earliest dropout, the CC group
showed less improvement than in the other four retention patterns, while the NAVIGATE
group showed greater improvement than in the four retention patterns with later dropout.
Treatment Effectiveness in Outcomes in PMMM

Author Manuscript

We next examine the change in magnitude of treatment effects for NAVIGATE vs. CC, on
each of the three major outcomes, between the original mixed model and the best fit
PMMM, the one based on the last visit but including those with intermittent missing data as
a separate retention pattern. For the primary outcome, the total QLS score, the treatment
effect of the NAVIGATE group over CC using PMMM was 7.40 (SE 2.66) points, compared
to 5.90 (SE 2.41) using the mixed model alone (Table 3), representing an increase in
effectiveness of 25.4% (Table 3). In addition, the p-value is much lower than in the original
mixed model analysis falling to p=.006 (last column, Table 3).
For the total PANSS score, the treatment effect of the NAVIGATE group over CC was −6.04
(SE 2.20) points using PMMM, compared to only −4.32 (SE 1.79) points using the mixed
model, representing an increase in effectiveness of 39.8% (last column, Table 3). The pvalue is also much lower than in the original mixed model analysis falling to .006. For the
CDSS, the treatment effect of the NAVIGATE group over CC using PMMM was −1.28 (SE
0.48) points, compared to only −0.79 (SE 0.37) using the mixed model, an increase in
improvement of 62.0% (last column, Table 3).

DISCUSSION

Author Manuscript

This study demonstrates an approach to the problem of differential retention between
treatment groups using PMMMs in an examination of the outcomes of a cluster-randomized
trial of treatment for first episode psychosis. Using PMMM, the benefits of NAVIGATE
appeared to be notably larger for the analysis of three standardized scales (QLS, PANSS,
and CDSS) than in the standard mixed model analysis without PMM, with a better goodness
of fit. The benefits of NAVIGATE over CC were estimated to be greater by 26% to 65% than
previously estimated.
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We found substantial differences in outcome trajectories between retention patterns even
though there were very few differences in baseline characteristics associated with retention.
A key finding was that there were differences in outcome trajectories between different
retention patterns that were only revealed using the pattern mixture model. Because patients
in CC were more likely to dropout (Table 1 Row 1) and patients who dropped out earlier
were worse off, in the retention patterns with earlier dropouts (Table 4), the estimated
pattern-specific treatment effects between NAVIGATE and the CC were greater, and this
greater difference was identified in the PMMM but not in regular mixed models. A plausible
interpretation of this finding is that study participants may have dropped out of the two
treatment groups for different reasons. Early dropouts in the NAVIGATE group may have
benefited more during the early phases of the trial when the NAVIGATE intervention
provided much greater intensity of service delivery, and may have dropped out when they
felt they no longer needed the treatment program. In contrast, participants in CC may have
been discouraged by the limited treatment they received. Poorer functioning participants
who failed to improve may have drop out early in treatment. These differences in reasons for
dropping out may have been most marked early in the study when the intensity of service
delivery between the two programs differed most, with similar reasons for dropping out
emerging over time for both groups. The substantial differences in pattern-specific effect
between groups among these early dropouts appears to account for the increased estimates
of the relative effectiveness of NAVIGATE in the PMM analysis as compared to the original
mixed models. These differences in pattern-specific effects between retention patterns did
not achieve statistical significance most likely because of the small number of patients in
each retention stratum. Nevertheless, these findings demonstrate that there are differences in
estimated benefits between retention patterns and that taking these differences into account
gives a more accurate picture of the trial results, as indicated by better model fit indices, and
one that shows the benefits of NAVIGATE in a more positive light than the original analyses.
The results of this analysis of the RAISE-ETP trial using PMMM strengthen the positive
findings of the original RAISE-ETP study analyses (Kane et al., 2016), and reinforces the
findings of several previous studies showing that coordinated specialty care programs
improve the outcomes of first episode psychosis (Heinssen et al., 2014).

Author Manuscript

From the research methods perspective, this is only the seventh randomized trial of
schizophrenia treatment outcomes that we could identify that used the PMM method to
address differential study retention (Harris et al., 2006; Hedeker and Gibbons, 1997; Hill et
al., 2004; Kong and Chen, 2016; Reilly et al., 2005; Rybin et al., 2015). Application of the
PMM method to two previous randomized trials for schizophrenia was similar to the
analysis presented here and compared the PMM results to standard mixed model results, but
found no indication of better goodness of fit nor any substantial differences in effectiveness
estimates between randomized treatment groups (Harris et al., 2006; Hedeker and Gibbons,
1997). Two other studies that used PMM in schizophrenia treatment trials did not compare
the results between PMM and standard mixed models (Hill et al., 2004; Rybin et al., 2015).
Rybin et al. (2015) performed a sensitivity analysis of a schizophrenia trial examining the
effect of various departures from the missing at random assumption in a simulation analysis
and found that such departures did not threaten the validity of the original findings. Kong
and Chen (2016) compared a latent growth mixture model to a pattern mixture model and
Schizophr Res. Author manuscript; available in PMC 2019 May 01.

Sint et al.

Page 9

Author Manuscript

expressed preference for the former due to its greater flexibility since subgroups with
differing outcome trajectories are not necessarily defined by the missing data patterns.

Author Manuscript

The lack of evidence that PMM changes outcome evaluations in schizophrenia trials, even
though they reported dropout rates ranging from 21% to 68%, may explain why the effective
method for incomplete data has been used so few times, although it has been available to
researchers for over 20 years. While the reasons for this limited use are not clear, the results
presented here should encourage further use of this approach in studies that are characterized
by substantial rates of attrition even when treatment groups do not have significantly
different rates of attrition. One of the striking findings of this study is that even though there
was no difference in attrition rate after the first follow-up assessment at 6 months, subgroups
with different patterns of attrition showed different outcome trajectories, possibly due to
different reasons of dropout between the two treatment conditions. It is thus advisable to
evaluate the relevance of PMM whenever there is substantial attrition to see if there are
differences in outcomes between groups with different patterns of attrition. The examination
of a larger number of retention patterns with pattern-specific mixed models may provide an
explanation of the fact that we found differences in outcome trajectories with PMMs in this
study while other studies did not find such differences.
Several methodological limitations of this study require comment. First, statistical power in
this study is limited, due to small sample size and clustering of patients within sites, which
may have impaired our ability to finding statistically significant differences between
outcomes across retention patterns or between PMMM analyses and standard mixed model
analyses.

Author Manuscript

A second limitation is that while the use of pattern mixture models in a mixed effects model
is a relatively simple extension of the mixed effects model, it does not improve model fit for
all outcomes. We found the stratification based on the last visit with intermittent data as a
separate retention pattern achieved the best fit for the QLS, the PANSS, and the CDSS, but it
did not yield a better fit for other outcomes.
Third, since 83 patients (20.5%) left the study before the first post-baseline visit at 6 months,
for whom, an intercept only mixed model was fitted in their own stratum and modelpredicted outcomes for these patients were not obtainable at the end of the 24 months in
PMMM as there was no slope of time for them and we did not make further assumption for
these patients on their 24-month’ outcomes.

Author Manuscript

This study suggests both substantive and methodological conclusions. It shows that
coordinated specialty care for first episode psychosis is effective and may have been even
more effective in the RAISE-ETP trial than had previously been estimated.
Methodologically, it shows that pattern mixture models can give a more accurate perspective
on the outcomes and the treatment effect of randomized clinical trials even when there are
limited differences in baseline characteristics associated with retention. PMM should be
more widely employed in the analysis of randomized clinical trials with substantial missing
data as part of a standard sensitivity analysis.
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Refer to Web version on PubMed Central for supplementary material.
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Appendix
SAS code for fitting pattern mixture mixed-effects model:
* Standard model;
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proc mixed data=raise2;
class site subject_id time6c;
model qlsts = sqrttime1m trt*sqrttime1m male studntyn_bl pants_bl / solution;
random intercept sqrttime1m / subject=site type=un;
random intercept sqrttime1m / subject=subject_id(site) type=un;
repeated time6c / subject=subject_id(site) type=un;
run;
* Code for last visit pattern in PMMM;

Author Manuscript

%macro patmix(outcome, covariates);
title “&outcome.”
proc mixed data=raise2;
class site subject_id time6c;
model &outcome. = sqrttime1m trt*sqrttime1m &covariates.
lastvisit1 trt*lastvisit1 lastvisit1*sqrttime1m trt*lastvisit1*sqrttime1m
lastvisit2 trt*lastvisit2 lastvisit2*sqrttime1m trt*lastvisit2*sqrttime1m
lastvisit3 trt*lastvisit3 lastvisit3*sqrttime1m trt*lastvisit3*sqrttime1m

Author Manuscript

/ solution;
random intercept sqrttime1m / subject=site type=un;
random intercept sqrttime1m / subject=subject_id(site) type=un;
repeated time6c / subject=subject_id(site) type=un;
contrast ‘test pattern terms’
lastvisitl 1,
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lastvisit2 1,
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lastvisit3 1,
lastvisit1*sqrttime1m 1,
lastvisit2*sqrttime1m 1,
lastvisit3*sqrttime1m 1,
trt*lastvisit1*sqrttime1m 1,
trt*lastvisit2*sqrttime1m 1,
trt*lastvisit3*sqrttime1m 1;
estimate ‘g4 - change from BL at 24m CC’

Author Manuscript

sqrttime1m 4.899;
estimate ‘g4 - change from BL at 24m NAV’
sqrttime1m 4.899 trt*sqrttime1m 4.899;
estimate ‘g4 - difference in change at 24m’
trt*sqrttime1m 4.899;
***;
estimate ‘g1 - change from BL at 24m CC’
sqrttime1m 4.899
lastvisit1*sqrttime1m 4.899;

Author Manuscript

estimate ‘g1 - change from BL at 24m NAV’
sqrttime1m 4.899 trt*sqrttime1m 4.899
lastvisit1*sqrttime1m 4.899 trt*lastvisit1*sqrttime1m 4.899;
estimate ‘g1 - difference in change at 24m’
trt*sqrttime1m 4.899
trt*lastvisit1*sqrttime1m 4.899;
***;
estimate ‘g2 - change from BL at 24m CC’

Author Manuscript

sqrttime1m 4.899
lastvisit2*sqrttime1m 4.899;
estimate ‘g2 - change from BL at 24m NAV’
sqrttime1m 4.899 trt*sqrttime1m 4.899
lastvisit2*sqrttime1m 4.899 trt*lastvisit2*sqrttime1m 4.899;
estimate ‘g2 - difference in change at 24m’
Schizophr Res. Author manuscript; available in PMC 2019 May 01.
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trt*sqrttime1m 4.899

Author Manuscript

trt*lastvisit2*sqrttime1m 4.899;
***;
estimate ‘g3 - change from BL at 24m CC’
sqrttime1m 4.899
lastvisit3*sqrttime1m 4.899;
estimate ‘g3 - change from BL at 24m NAV’
sqrttime1m 4.899 trt*sqrttime1m 4.899
lastvisit3*sqrttime1m 4.899 trt*lastvisit3*sqrttime1m 4.899;

Author Manuscript

estimate ‘g3 - difference in change at 24m’
trt*sqrttime1m 4.899
trt*lastvisit3*sqrttime1m 4.899;
***;
estimate ‘change from BL at 24m CC’
sqrttime1m 4.899
lastvisit1*sqrttime1m 0.612 /* 4.899*0.125 */
lastvisit2*sqrttime1m 0.563 /* 4.899*0.115 */
lastvisit3*sqrttime1m 0.593 /* 4.899*0.121 */;

Author Manuscript

estimate ‘change from BL at 24m NAV’
sqrttime1m 4.899 trt*sqrttime1m 4.899
lastvisit1*sqrttime1m 0.612 trt*lastvisit1*sqrttime1m 0.612
lastvisit2*sqrttime1m 0.563 trt*lastvisit2*sqrttime1m 0.563
lastvisit3*sqrttime1m 0.593 trt*lastvisit3*sqrttime1m 0.593;
estimate ‘difference in change at 24m’
trt*sqrttime1m 4.899
trt*lastvisit1*sqrttime1m 0.612

Author Manuscript

trt*lastvisit2*sqrttime1m 0.563
trt*lastvisit3*sqrttime1m 0.593;
estimate ‘change from BL at 24m CC - based on within trt’
sqrttime1m 4.899
lastvisit1*sqrttime1m 0.725 /* 4.899*0.148 = 0.725 */
lastvisit2*sqrttime1m 0.725 /* 4.899*0.148 = 0.725 */
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lastvisit3*sqrttime1m 0.691 /* 4.899*0.141 = 0.691 */;

Author Manuscript

estimate ‘change from BL at 24m NAV - based on within trt’
/*
4.899*0.108 = 0.529
4.899*0.091 = 0.446
4.899*0.108 = 0.529
*/
sqrttime1m 4.899 trt*sqrttime1m 4.899
lastvisit1*sqrttime1m 0.529 trt*lastvisit1*sqrttime1m 0.529

Author Manuscript

lastvisit2*sqrttime1m 0.446 trt*lastvisit2*sqrttime1m 0.446
lastvisit3*sqrttime1m 0.529 trt*lastvisit3*sqrttime1m 0.529;
estimate ‘difference in change at 24m - based on within trt’
/*
0.529 – 0.725 = −0.196
0.446 – 0.725 = −0.279
0.529 – 0.691 = −0.162
*/
trt*sqrttime1m 4.899

Author Manuscript

lastvisit1*sqrttime1m −0.196 trt*lastvisit1*sqrttime1m 0.529
lastvisit2*sqrttime1m −0.279 trt*lastvisit2*sqrttime1m 0.446
lastvisit3*sqrttime1m −0.162 trt*lastvisit3*sqrttime1m 0.529;
run;
title ““;
%mend;
%patmix(qlsts, male studntyn_bl pants_bl);
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Table 1

Author Manuscript

Patient characteristics associated with study dropout
Categorical Variables

Baseline Hazard Ratio (95% CI)

p-value

CC vs. NAVIGATE

1.55 (1.08, 2.22)

0.0165

DUP > 74

1.11 (0.83, 1.48)

0.47

Male

1.11 (0.81, 1.52)

0.53

Race

0.31

White

1

African American

1.25 (0.9, 1.74)

Other

1.31 (0.79, 2.18)

Hispanic ethnicity
Marital status

0.24

Author Manuscript

Presently married

0.62 (0.31, 1.24)

Widowed/divorced/separated

0.66 (0.32, 1.37)

Never married

1

Current residence

0.49

Independent living

1

Supported or structured

1.27 (0.54, 2.99)

Family, parents, grandparents, sibling

1.2 (0.8, 1.8)

Homeless, shelter, or other

1.59 (0.88, 2.88)

Patient’s education

0.77

Author Manuscript

Some college or higher

1

Completed high school

1.14 (0.79, 1.64)

Some high school

1.21 (0.84, 1.75)

Some or completed grade school

1.19 (0.63, 2.25)

Current student

1

0.99

Currently working

0.97 (0.64, 1.46)

0.87

Student or working

0.85 (0.61, 1.16)

0.30

Prescribed one or more antipsychotics at consent

1.3 (0.9, 1.87)

0.16

Number of prior hospitalizations

0.91

0

1

1

1.13 (0.78, 1.65)

2

1.05 (0.66, 1.67)

3 or more

1.02 (0.63, 1.64)

Medication compliance

Author Manuscript

Days not taking 1st antipsychotic

0.41

Few if any, <7

1

7 to 13

1.53 (0.85, 2.74)

14 to 20

0.88 (0.38, 2.02)

Most, >20

0.74 (0.34, 1.61)
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Baseline Variable

Time-varying Variable

Continuous Variable

Author Manuscript

Hazard Ratio (95% CI)

p-value

Hazard Ratio (95% CI)

p-value

Age

0.97 (0.935, 0.995)

0.024

N/A

Duration of untreated psychosis (weeks)

1.000 (0.999, 1.000)

0.85

N/A

Total score

0.994 (0.986, 1.002)

0.13

0.995 (0.988, 1.002)

0.14

Interpersonal relations

0.990 (0.974, 1.007)

0.23

0.991 (0.976, 1.006)

0.23

Instrumental role

0.994 (0.972, 1.016)

0.57

0.990 (0.970, 1.011)

0.36

Intrapsychic foundations

0.986 (0.966, 1.007)

0.19

0.991 (0.972, 1.010)

0.35

Common objects and activities

0.934 (0.878, 0.995)

0.03

0.928 (0.873, 0.986)

0.02

1.006 (0.997, 1.016)

0.19

1.002 (0.993, 1.011)

0.62

Positive

0.986 (0.950, 1.023)

0.46

0.998 (0.963, 1.034)

0.92

Negative

1.009 (0.981, 1.038)

0.51

1.001 (0.975, 1.028)

0.93

Disorganized/concrete

1.018 (0.966, 1.071)

0.51

1.019 (0.966, 1.075)

0.50

Excited

1.044 (0.992, 1.098)

0.10

1.032 (0.982, 1.086)

0.22

Depressed

1.043 (0.998, 1.089)

0.06

1.002 (0.96, 1.046)

0.92

CDSS

1.033 (0.999, 1.067)

0.05

1.012 (0.979, 1.047)

0.47

CGI

0.998 (0.838, 1.188)

0.98

1.015 (0.869, 1.185)

0.85

Number of days of alcohol intoxication

0.941 (0.859, 1.031)

0.19

0.918 (0.823, 1.023)

0.12

Number of days of illegal drugs

1.003 (0.985, 1.022)

0.73

0.994 (0.975, 1.015)

0.58

How likely to complete study?

0.984 (0.908, 1.066)

0.69

0.928 (0.856, 1.006)

0.07

How likely to attend next assessment?

1.021 (0.928, 1.123)

0.68

0.905 (0.838, 0.977)

0.01

Quality of Life Scale for Schizophrenia

PANSS
Total score
Factor scores

Author Manuscript
Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript
67
155

4

48.3

20.9

15.3

15.6

---

%

60

30

21

24

46 (25.4%)

N

44.4

22.2

15.6

17.8

---

%

Community Care

95

37

28

26

37 (16.6%)

N

51.1

19.9

15.1

83 (20.5%)
40
37
39
205

Month 0

Month 6

Month 12

Month 18

Month 24

63.9

12.1

11.5

12.5

---

%

76

19

20

20

46 (25.4%)

N

56.3

14.1

14.8

14.8

---

%

Community Care

129

20

17

20

37 (16.6%)

N
---

%

69.4

10.8

9.1

10.8

NAVIGATE
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Intermittent

19.3

48.3

9.3

10.6

12.5

---

%

20

60

17

18

20

46 (25.4%)

N

14.8

44.4

12.6

13.3

14.8

---

%

Community Care

Including patients with no follow-up visits: χ2 = 6.39, df=4, p=0.17

Excluding patients with no follow-up visits: χ2 = 1.65, df=3, p=0.65

42

95

13

16

20

37 (16.6%)

N
---

%

22.6

51.1

7.0

8.6

10.8

NAVIGATE

Including patients with no follow-up visits: χ2 = 10.70, df=4, p=0.03

30

Month 12

155

34

Month 6

Month 24

40

Month 0

Month 18

N

83 (20.5%)

Last visit

All patients

c. Last follow-up visit with intermittent follow-up visits as a separate category

N

Last visit

All patients

---

%

14.0

NAVIGATE

b. Last follow-up visit with intermittent follow-up visits accounted in the visit

49

3

50

2

83 (20.5%)

1

N

0

# follow- up visits

All patients

a. Number of follow-up visits

Author Manuscript

The number and proportion of patients in three types of patterns

Author Manuscript

Table 2
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Author Manuscript
Excluding patients with no follow-up visits: χ2 = 8.47, df=4, p=0.08

Including patients with no follow-up visits: χ2 = 13.11, df=5, p=0.02

Excluding patients with no follow-up visits: χ2 = 6.02, df=3, p=0.11
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CDSS total score

PANSS total score

QLS total score

−4.32

0.016
11118.0
−1.20
−1.98

−0.79

0.032
7344.7

Diff.
between 2
groups
p-val.
BIC
CC
NAV
Diff.
between 2
groups
p-val.
BIC

−10.15

−9.99
−14.31

11411.2

BIC
CC

0.015

p-val.

NAV

11367.3

5.90

0.37

0.28

0.33

1.79

1.14

1.38

2.41

7333.5

0.0226

−0.97

−1.89

−0.93

11055.4

−4.55

−14.70

0.0055

7.04

15.57

Diff.
between 2
groups

1.62

15.79

8.54

NAV

1.92

0.42

0.32

0.39

1.90

1.16

1.51

2.52

1.67

2.05

22.8%

−4.5%

−22.5%

5.3%

2.7%

1.6%

19.3%

−1.4%

−13.7%

7329.7

0.0177

−1.15

−2.22

−1.07

11038.9

0.0065

−5.87

−15.57

−9.70

11366.0

0.0085

7.09

16.19

9.10

Mean Change

0.48

0.35

0.43

2.15

1.33

1.69

2.69

1.80

2.18

SE

45.6%

12.1%

−10.8%

35.8%

8.8%

−2.9%

20.2%

2.5%

−8.0%

% diff.
from MM

SE

% diff.
from MM

Mean Change

9.89

SE

PMMM based on time of last visit

PMMM based on number of visits

CC

Mean Change

Standard Mixed Model
(MM)

Author Manuscript

Mean Change at 24 Months from Baseline between CC and NAVIGATE

7323.6

0.0078

−1.28

−2.23

−0.95

11033.8

0.0061

−6.04

−15.51

−9.47

11353.8

0.0056

7.40

16.15

8.76

Mean Change

0.48

0.35

0.43

2.20

1.37

1.72

2.66

1.78

2.16

SE

62.0%

12.6%

−20.8%

39.8%

8.4%

−5.2%

25.4%

2.3%

−11.4%

% diff.
from MM

PMM based on the time of last visit and
intermittent missingness

Author Manuscript

Table 3
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Author Manuscript
10.29

Month 12

7.62
8.76
9.89

Overall PMMM

Mixed Model
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1.85

−10.45
−7.91
−9.47
−9.99

Month 24

Intermittent

Overall PMMM

Mixed Model

1.38

1.72

3.44

0.08
−1.48
−2.32

Month 12

Month 18

Mean Change

1.07

1.24

1.96

SE

Community Care

Month 6

Retention Pattern

c. CDSS

4.50

−12.81

Month 18

4.91

−12.55

Month 12

7.67

SE

−2.47

Mean Change

Community Care

1.92

2.06

Month 6

Retention Pattern

b. PANSS

2.46

9.93

Month 24

Intermittent

4.34

5.26

6.27

8.56

SE

11.18

Month 18

2.92

Mean Change

Community Care

Month 6

Retention Pattern

a. Quality of life (QLS)

0.14

0.50

0.74

p*

0.52

Ref.

0.63

0.69

0.31

p*

0.64

Ref.

0.83

0.96

0.43

p*

1.62

1.88

3.08

2.03

5.96

6.61

8.57

SE

1.14

1.37

2.39

1.47

5.13

5.21

7.67

SE

−0.70

−4.29

−5.30

Mean Change

1.17

1.32

1.96

SE

NAVIGATE

−14.31

−15.51

−11.05

−13.72

−11.37

−20.09

−32.35

Mean Change

NAVIGATE

15.79

16.25

13.73

16.13

4.43

26.99

20.28

Mean Change

NAVIGATE

0.37

0.07

0.08

p*

0.34

Ref.

0.66

0.24

0.0174

p*

0.50

Ref.

0.06

0.11

0.64

p*

2.41

2.65

5.15

3.06

7.63

8.58

11.52

SE

1.62

−2.81

−5.38

Mean Change

SE

1.31

1.51

2.53

SE

p*

0.32

0.11

p*

0.98

Ref.

0.51

0.57

0.0168

9.89

8.76

7.62

9.93

11.18

10.29

2.92

p*

0.0402

1.79

2.20

4.19

2.36

6.83

7.16

10.85

Difference

−4.32

−6.04

−3.14

−3.27

1.44

−7.54

−29.88

Mean Change

Difference

5.90

7.49

6.11

6.20

−6.76

16.71

17.36

Mean Change

Difference

Mean Change at End of Study from Baseline by Retention Pattern based on Time of Last Visit and Intermittent Missingness (Approach 3)
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−0.95
−1.20

Overall PMMM
Mixed Model

0.33

0.43

Ref.
0.38

−1.98

−2.23

−1.38

−1.82

0.28

0.35

0.62

0.38

SE

p-values for the difference in the mean change comparing to the referent pattern.

p-values for the difference in the mean change comparing to the referent pattern.

*

*

−1.40

Mean Change

NAVIGATE

p-values for the difference in the mean change comparing to the referent pattern.

*

0.44

−0.59

Month 24
Intermittent

0.80

SE

Mean Change

Retention Pattern

p*

Author Manuscript
Community Care

0.55

Ref.

p*

−0.79

−1.28

0.02

−1.23

Mean Change

0.37

0.48

0.84

0.46

SE

Difference
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